Given the momentous effects of E2F2 in cancers, Li et al. [10] suggested that E2F2 polymorphisms could be utilized to predict the risk of oropharynx squamous cell carcinoma recurrence. This evidence concerns the gene E2F2 and oropharynx squamous cell carcinoma.